comparsion of two different drug effect for awake fiberoptic intubation.
Phase 4
- Conditions
- Health Condition 1: C069- Malignant neoplasm of mouth, unspecifiedHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2022/02/040614
- Lead Sponsor
- mahatma gandhi medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient scheduled for awake fiberoptic intubation under general anaesthesia.
Patient posted for surgery under general anaesthesia
Patient with ASA class I and II
Written informed consent for the study.
Exclusion Criteria
patient with ASA class III, IV, V
Non-consenting patients
patient with pre existing cardiac disease
severe renal or hepatic dysfunction
patient with known allergy to study drugs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To observe the hemodynamic response of the patients after awake fiberoptic nasal intubation.Timepoint: baseline, at intubation, 1min, 5 min, 10 min, 15 min,30min,45 min,60min.
- Secondary Outcome Measures
Name Time Method To observe the OAA Score, cough score, limb movement ,five-point intubation comfort score and three point post -intubation score under awake fiberoptic nasal intubation.Timepoint: at the time of intubation within 10 mins.